Palemo Holdings
2778
Renascience
4889
Oncolys BioPharma
4588
Spancrete
5277
Kitagawa Seiki
6327
JP Stock MarketDetailed Quotes
2121 mixi
- 2941
- +50+1.73%
20min DelayTrading Jan 22 15:08 JST
216.84BMarket Cap29.84P/E (Static)
2968High2885Low329.10KVolume2887Open2891Pre Close966.95MTurnover343052wk High0.97%Turnover Ratio73.73MShares237352wk Low141.62EPS TTM99.62BFloat Cap7300Historical High29.84P/E (Static)33.87MShs Float5Historical Low98.56EPS LYR2.87%Amplitude110.00Dividend TTM1.15P/B100Lot Size3.74%Div YieldTTM
mixi News
mixi: Report on the status of share buybacks (based on Article 24-6, Paragraph 1 of the law).
mixi: Notice regarding completion of submission of the half-year report for the fiscal year ending March 31, 2025
mixi: Notice regarding important deficiencies in internal controls related to financial reporting that should be disclosed and submission of revised reports on internal control reports
mixi: Revised Internal Control Report - 25th Term (2023/04/01 - 2024/03/31)
mixi: Revised Internal Control Report - 24th Term (2022/04/01 - 2023/03/31)
mixi: Revised Internal Control Report - 23rd Term (2021/04/01 - 2022/03/31)
mixi: Confirmation
mixi: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)
mixi: Notice regarding formulation of measures to prevent recurrence and voluntary return of executive remuneration
mixi: Half Year Report - Term 26 (2024/04/01 - 2025/03/31)
mixi: Notice regarding the status of treasury stock repurchases
mixi: (Correction) Partial correction to “Notice of receipt of investigation reports etc. by the investigation team”
mixi: Notice of receipt of investigation reports etc. by the investigation team
mixi: Report on the status of share buybacks (based on Article 24-6, Paragraph 1 of the law).
mixi: Notice regarding the status of treasury stock repurchases
mixi: Treasury stock purchase status report (based on Act Section 24-6 (1))
mixi: Notice of approval relating to the extension of the deadline for submission of the half-year report for the fiscal year ending 2025/3
mixi: Notice of submission of an application for approval regarding the extension of the submission deadline for the half-year report for the fiscal year ending 2025/3
mixi: Notice regarding dividends from surplus funds
mixi: Notice regarding the postponement of the announcement of financial results for the 2nd quarter of the fiscal year ending March 31, 2025 and consideration of an application for an extension of the submission deadline for the half-year report
